BSE filing, NSE: EMKAY. Summary written from the filing by ALFA Finder's alert engine.
Emkay Global Financial Services Ltd: key numbers
- Share price
- ₹258.35
- Market cap
- ₹721.7 Cr
- Revenue (annual)
- ₹377.0 Cr
- Net profit (annual)
- ₹15.20 Cr
- P/E (TTM)
- 14.4×Sector 19.5×
- Promoter holding
- 72.89%+0.06% QoQ
- FII holding
- 0.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emkay Global Financial Services Ltd
All →Emkay Global Financial Services Convertible Warrants
Emkay Global received NSE and BSE trading approval for 1,00,000 equity shares issued to promoter Prakash Kacholia on conversion of preferential warrants. Shares are admitted to dealings from 4 November 2026, subject to an 18-month lock-in.
Emkay Global Financial Services Capital Structure Change
Emkay Global will invest ₹30.00 Crore in cash in wholly owned subsidiary Emkay Capital. The related-party deal completes within 90 days.
- Value
- ₹30.00 Cr
- Execution
- Within 90 days
Emkay Global Financial Services Acquisition Worth ₹30 Cr
Emkay Global will buy Emkay Capital Private Limited for Rs 30 Crore in cash. The related-party deal is expected to complete within 90 days.
- Value
- ₹30.00 Cr
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
Emkay Global Financial Services Acquisition Worth ₹2.05 Cr
Emkay Capital, a subsidiary of Emkay Global, agreed to acquire Emkay Wealth Advisory for Rs. 2.05 Crore cash. The deal is an intra-group restructuring, and the target is a SEBI-registered investment adviser.
- Value
- ₹2.05 Cr
- Execution
- 90 days
Emkay Global Financial Services Acquisition Worth ₹21.38 Cr
Emkay Capital, a subsidiary, will acquire Emkay Investment Managers for Rs.21.38 Crore cash. The related-party deal is at arm's length and payable in tranches.
- Value
- ₹21.38 Cr
- Execution
- 90 days
Other other announcement announcements
All →Dr. Reddy's Laboratories Other Announcement
Dr Reddy's KMP Erez Israeli sold 460,276 ADRs to cover the exercise of 591,270 ADRs allotted under ESOP. The disposal is valued at about ₹61.76 Crore.
- Value
- ₹61.76 Cr
Addictive Learning Technology Other Announcement
Addictive Learning Technology filed its half-year IPO proceeds utilisation statement under Reg 32. Reallocations moved Rs.521.32 lakh to working capital, with Rs.200 lakh unused.
JSW Dulux Other Announcement
JSW Dulux Limited filed an Audio/Video Recording intimation dated 4 November 2026 with a link to its investor page. The filing carries no transaction, financial figures, or disclosed content of the call.
CLIO Infotech Other Announcement
Clio Infotech reported no deviation in its preferential issue fund utilisation for the quarter. Rs 3,17,145 of earlier unutilised funds were used during the period.
Sattva Sukun Lifecare Other Announcement
Tavexia Lifecare Ltd board approved changing its RTA from Niche Technologies to Skyline Financial Services. Niche continues until data transition and depository confirmations are complete.
Gabion Technologies India Other Announcement
Gabion Technologies re-appointed VRSK & Associates as internal auditor, effective 4 November 2026, for a one-month term. Routine auditor re-appointment with no material business impact.